GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
Part of paid clinical trials in Kansas City, Kansas.
- Sponsor
- University of Kansas Medical Center
- Study ID
- NCT07422987
- Status
- Recruiting
Conditions
- Body Composition
- Estrogen Level
- GLP-1
- Muscle Function
Eligibility Criteria
- Sex
- FEMALE
- Age
- 35 Years - 60 Years
- Healthy Volunteers
- Accepted
Study Details
This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.
Key Dates
- Start date
- Feb 12, 2026
- Status verified
- Feb 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: GLOW ParticipantsNew patients, those who are newly prescribed a GLP-1RA medication will be invited to participate in the study where different measurements will be completed to assess body composition, hormone levels, muscle strength and nutrition.
Primary Outcome Measure
Body weight [ Time Frame: Baseline through 6-month visit ]
Central Contacts
- Johanna Finkle, MD(913) 588-5478
- Holly Hull, PhD913-945-5838
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Kansas Medical Center | Kansas City | Kansas | 66160 | - |
Find similar trials in Kansas City, KS
By research site
Related Studies
- DXA Study of Precision and ReliabilityRecruiting · Penn State University · University Park, Pennsylvania
- Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding DifficultyRecruiting · Nemours Children's Clinic · Orlando, Florida
- Targeting Aging With a Ketone Ester for Function in FrailtyRecruiting · Buck Institute for Research on Aging · Novato, California
- MAINTAIN (Mucosal AblatIoN Therapy After INcretins)Recruiting · Dr. Christopher McGowan · Cary, North Carolina